FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and represents a drug possessing antiviral, anti-inflammatory, immunomodulatory and analgesic action for local and external applications, containing alpha- or beta- or gamma-recombinant interferon, acyclovir and lidocaine, oleic acid and a consistency-forming base, characterized by the fact that the drug further contains L-lysine, Nipasol, disodium edetate, cetyl alcohol, stearyl alcohol, glyceryl monostearate, carbomer, polyethylene glycol glycerol ricinoleate, polyethylene glycol glycerol hydroxystearate, trolamine, macrogol 400 and water, with the ingredients of the drug taken in certain ratio in mg per 1 g of the mixture.
EFFECT: invention provides the relief of the infectious process at the stage of latent signs of the disease, prolongs remission, reduces the length of treatment at the clinical stage of the disease up to 1-2 days.
3 ex
Title | Year | Author | Number |
---|---|---|---|
CO-DRUG EXHIBITING ANTIMYCOTIC, ANTIVIRAL, ANTIMICROBIAL, ANTI-INFLAMMATORY, IMMUNOMODULATING AND BACTERICIDAL ACTION FOR EXTERNAL OR LOCAL APPLICATION | 2010 |
|
RU2431497C1 |
PHARMACEUTICAL COMPOSITION DENTOFERON IN FORM OF GEL FOR PREVENTING AND TREATING PERIODONTAL DISEASES | 2012 |
|
RU2490006C1 |
ANTIVIRAL AGENT - EYE DROPS | 2012 |
|
RU2473363C1 |
ANTIVIRAL AGENT IN LIQUID FORM AND METHOD FOR ITS PREPARATION | 2021 |
|
RU2768656C1 |
MEDICINAL FOR VAGINAL APPLICATION, WITH ANTIVIRAL, ANTIMICROBIAL, ANTIFUNGAL, ANTIPROTOZOAL, ANTIINFECTIOUS, IMMUNOMODULATING AND ANTIINFLAMMATORY ACTION, AS OINTMENT, GEL, SUPPOSITORY | 2016 |
|
RU2633056C1 |
CURATIVE AGENT | 2000 |
|
RU2187332C1 |
TABLETTED PHARMACEUTICAL COMPOSITION FOR TREATING SEVERE FORMS OF VIRAL INFECTIONS | 2014 |
|
RU2559179C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING DEMODECOSIS, POSSESSING ANTIPARASITIC, ANTIBACTERIAL, ANTIVIRAL, IMMUNOMODULATORY ACTION | 2013 |
|
RU2538710C1 |
PHARMACEUTICAL COMPOSITION IN FORM OF CAPSULE POSSESSING ANTIVIRAL, ANTI-INFLAMMATORY, ANTIMICROBIAL AND IMMUNOMODULATORY ACTION | 2012 |
|
RU2482872C1 |
PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF PAPILLOMATOSIS OF VARIOUS LOCALISATION | 2013 |
|
RU2537232C1 |
Authors
Dates
2013-07-27—Published
2012-07-17—Filed